The CLL Sessions: highlights from EHA and ICML 2021
VJHemOnc Podcast
Progression-free survival of patients with P53 aberrations and comparison of VTK inhibitors
Discussion on the progression-free survival of patients with P53 aberrations after therapy, including the impact of treatment duration and comparison of VTK inhibitors in head-to-head studies.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
